16 05, 2024 Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B Neal Evan Caminsky2024-05-16T09:19:07-04:00May 16, 2024|Funded Research Results, Pillar 4|
11 04, 2024 A universal sequencing read interpreter Neal Evan Caminsky2024-04-11T12:23:38-04:00April 11, 2024|Funded Research Results, Pillar 4|
11 04, 2024 A multi-kingdom genetic barcoding system for precise target clone isolation Neal Evan Caminsky2024-04-11T12:22:30-04:00April 11, 2024|Funded Research Results, Pillar 4|
27 09, 2023 Human-vision-inspired cluster identification for single-molecule localization microscopy Neal Evan Caminsky2024-12-16T09:50:07-05:00September 27, 2023|Funded Research Results, Pillar 4|
26 09, 2023 Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study Neal Evan Caminsky2023-09-26T10:49:59-04:00September 26, 2023|Funded Research Results, Pillar 4|
26 09, 2023 Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases Neal Evan Caminsky2023-09-26T10:41:44-04:00September 26, 2023|Funded Research Results, Pillar 4|
5 06, 2023 Phase 1 randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B Neal Evan Caminsky2023-06-05T15:18:38-04:00June 5, 2023|Funded Research Results, Pillar 4|
23 01, 2023 Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases Neal Evan Caminsky2023-01-23T10:01:17-05:00January 23, 2023|Funded Research Results, Pillar 4|
7 07, 2022 Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases Neal Evan Caminsky2022-11-15T09:12:18-05:00July 7, 2022|Funded Research Results, Pillar 4|
